Classification and Prediction of Difficult Awake Tracheal Intubation With Flexible Bronchoscopes (AirWake)

Airway management problems are key drivers for anesthesia-related adverse events. Awake tracheal intubation using flexible bronchoscopes with preserved spontaneous breathing (ATI:FB) is a recommended technique to manage difficult tracheal intubation in anesthesia, intensive care and emergency medicine. However, a prospective developed classification for this type of airway management is lacking. Due to the absence of a specifically tailored, validated classification for awake intubation with flexible bronchoscopes, many airway operators and institutions use classification tools that were originally developed for direct laryngoscopy, such as the percentage of glottic opening (POGO) score or Cormack-Lehane classification, although their diagnostic performance for the classification of ATI:FB is unknown. This prospective model development and validation study aims to develop two multivariable prediction models: a diagnostic prediction model to classify difficult ATI:FB after ATI:FB has been performed and a second prognostic prediction model to predict the risk for difficult ATI:FB before ATI:FB is performed. An additional aim is to develop a machine learning algorithm to evaluate ATI:FB.

Study Overview

Study Type

Observational

Enrollment (Estimated)

313

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Martin Petzoldt, MD, FEAMS
  • Phone Number: 04915222815932
  • Email: m.petzoldt@uke.de

Study Contact Backup

Study Locations

      • Hamburg, Germany, 20246
        • Recruiting
        • University Medical Center Hamburg-Eppendorf
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients with anticipated difficult airways scheduled for surgery with general anaesthesia and tracheal intubation at a single study center

Description

Inclusion Criteria:

  • Patients with an anticipated difficult airways scheduled for ATI:FB
  • Consent by the patient
  • Minimum 18 years of age

Exclusion Criteria:

  • Patients not scheduled for ATI:FB
  • Pregnant or breastfeeding patients
  • Consent not given by the patient

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difficult awake flexible bronchoscopic intubation
Time Frame: 1 hour
Difficult airway alert issued by the airway operator following ATI:FB
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of intubation attempts
Time Frame: 1 hour
Observed during airway management
1 hour
First attempt success
Time Frame: 1 hour
Number of participants with successful ATI:FB with only one attempt
1 hour
Number of bronchoscopy attempts
Time Frame: 1 hour
Observed during airway management
1 hour
Successful ATI:FB
Time Frame: 1 hour
Number of participants with successful ATI:FB
1 hour
Successful bronchoscopy
Time Frame: 1 hour
Number of participants with successful bronchoscopy
1 hour
Successful tube placement
Time Frame: 1 hour
Number of participants with successful tracheal tube placement
1 hour
Coversion to another type of airway management
Time Frame: 1 hour
Observed during airway management
1 hour
Conversion from transnasal to transoral bronchoscopy or vice versa
Time Frame: 1 hour
Observed during airway management
1 hour
Percentage of glottic opening
Time Frame: 1 hour
Grading of the best view obtained during laryngoscopy (%)
1 hour
Glottic view
Time Frame: 1 hour
Grading of the best view obtained using landmarks (6-stages)
1 hour
Time to best glottic view
Time Frame: 1 hour
Recorded during airway management (seconds)
1 hour
Time to intubation
Time Frame: 1 hour
Recorded during airway management (seconds)
1 hour
Lowest oxygen saturation
Time Frame: 1 hour
Measured during airway management (%)
1 hour
Endtidal CO2
Time Frame: 1 hour
First value measured after intubation (mmHg)
1 hour
Airway obstructions requiring external manipulation
Time Frame: 1 hour
Observed during airway management
1 hour
Hypoxia
Time Frame: 1 hour
Observed during airway management
1 hour
Cardiovascular event requiring intervention (hypotension/bradycardia)
Time Frame: 1 hour
Relevant hypotension or bradycardia observed during airway management
1 hour
Cardiovascular event requiring intervention (hypertension, tachycardia)
Time Frame: 1 hour
Relevant hypertension or tachycardia observed during airway management
1 hour
Additional manouvers and adjuncts used
Time Frame: 1 hour
Observed during airway management
1 hour
Patient discomfort during ATI:FB
Time Frame: 1 hour
Observed during airway management
1 hour
Airway-related complications
Time Frame: 1 hour
Observed during airway management
1 hour
Anaesthesia alert card issued
Time Frame: 1 hour
Anaesthesia alert card issued by the airway operator
1 hour
Recommendation for future airway management
Time Frame: 1 hour
Recommendation documented by the airway operator after airway management
1 hour
Richmond agitation-sedation Scale
Time Frame: 1 hour
Observed during airway management (scale form -4 to 5 points; lower values indicate deeper sedation)
1 hour
Subjective rating of difficulty of sedation, topicalisation, bronchoscopy and tube placement
Time Frame: 1 hour
Rating of the airway operator (visual analog scales [0-100]; lower values indicate better conditions)
1 hour
Preparation time
Time Frame: 1 hour
Recorded during airway management
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martin Petzoldt, MD, FEAMS, University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf
  • Principal Investigator: Vera Köhl, MD, University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 30, 2025

Primary Completion (Estimated)

January 31, 2026

Study Completion (Estimated)

January 31, 2026

Study Registration Dates

First Submitted

April 22, 2025

First Submitted That Met QC Criteria

April 29, 2025

First Posted (Actual)

May 1, 2025

Study Record Updates

Last Update Posted (Actual)

May 6, 2025

Last Update Submitted That Met QC Criteria

May 1, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Management

Subscribe